‘CM had even asked us to launch campaign’: Actors Shashi, Bhavana in shock after ticket denial

Mangaluru, Jan 23: City Police Commissioner PS Harsha on Thursday said that Aditya Rao, who had surrendered after planting a bomb at the Mangaluru International Airport, had studied how to assemble an explosive device online.

Speaking to media persons here, Dr Harsha said that 36-year-old Rao, who holds engineering and MBA degrees, had worked in the financial sector for some time, but left, after realising that white-collar jobs were not suited for him and turned towards blue-collar jobs.

He took up a job as a security guard of a reputed college in the district. He also worked at few hotels in the city before leaving for Bengaluru.

Bengaluru, Mar 21: All bars and pubs in Karnataka will remain closed from Saturday till March 31 as a preventive measure to tackle coronavirus spread, said state Chief Minister B S Yeddyurappa.

As per the government advisory, restaurants including cafes cannot serve food in-house and only takeaways will be allowed.

"All bars/pubs to remain closed from tomorrow till March 31 in Karnataka. In all city municipal corporations across the state, restaurants including cafes cannot serve food in-house, only takeaways will be allowed," said Yeddyurappa in a statement.

15 people have tested positive for COVID-19 in the state till now, said Karnataka Health Minister B Sriramulu on Friday.

The Minister told news agency that two COVID-19 patients, who are recovering, will soon be discharged from the hospital.

The total number of COVID-19 cases in India has now climbed up to 223, including 32 foreigners, the Union Health Ministry said on Friday. As many as 23 people have been cured of the infection in India.

The disease has claimed over 10,000 lives globally.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.